Sunshine Biopharma (SBFM) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Sunshine Biopharma (SBFM) over the last 8 years, with Q3 2025 value amounting to $636708.0.
- Sunshine Biopharma's Total Non-Current Liabilities rose 3019.89% to $636708.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $636708.0, marking a year-over-year increase of 3019.89%. This contributed to the annual value of $744724.0 for FY2024, which is 2670.46% up from last year.
- Per Sunshine Biopharma's latest filing, its Total Non-Current Liabilities stood at $636708.0 for Q3 2025, which was up 3019.89% from $706530.0 recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Total Non-Current Liabilities ranged from a high of $744724.0 in Q4 2024 and a low of $489027.0 during Q3 2024
- In the last 4 years, Sunshine Biopharma's Total Non-Current Liabilities had a median value of $638295.0 in 2023 and averaged $627026.4.
- As far as peak fluctuations go, Sunshine Biopharma's Total Non-Current Liabilities crashed by 2004.23% in 2024, and later surged by 3809.26% in 2025.
- Quarter analysis of 4 years shows Sunshine Biopharma's Total Non-Current Liabilities stood at $685264.0 in 2022, then decreased by 14.23% to $587764.0 in 2023, then rose by 26.7% to $744724.0 in 2024, then decreased by 14.5% to $636708.0 in 2025.
- Its Total Non-Current Liabilities was $636708.0 in Q3 2025, compared to $706530.0 in Q2 2025 and $722199.0 in Q1 2025.